IRIS
GEROLDI, DIEGO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.114
AS - Asia 2.301
EU - Europa 2.124
SA - Sud America 257
AF - Africa 88
OC - Oceania 6
Totale 7.890
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.060
CN - Cina 1.185
SG - Singapore 508
IE - Irlanda 463
UA - Ucraina 300
FI - Finlandia 271
DE - Germania 268
RU - Federazione Russa 227
BR - Brasile 207
HK - Hong Kong 197
VN - Vietnam 190
GB - Regno Unito 158
FR - Francia 116
IT - Italia 108
SE - Svezia 96
IN - India 62
ZA - Sudafrica 60
CA - Canada 32
JP - Giappone 27
BE - Belgio 26
PL - Polonia 25
BD - Bangladesh 21
IQ - Iraq 21
NL - Olanda 19
AR - Argentina 17
TR - Turchia 17
ES - Italia 16
MX - Messico 14
ID - Indonesia 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
MA - Marocco 9
CO - Colombia 8
CZ - Repubblica Ceca 6
EC - Ecuador 6
JO - Giordania 6
MY - Malesia 6
PK - Pakistan 6
AU - Australia 5
CL - Cile 5
PH - Filippine 5
VE - Venezuela 5
KE - Kenya 4
LT - Lituania 4
AT - Austria 3
IL - Israele 3
PE - Perù 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
LY - Libia 2
MU - Mauritius 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GA - Gabon 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SV - El Salvador 1
UY - Uruguay 1
ZM - Zambia 1
Totale 7.890
Salva come PNG Salva come JPEG
Città #
Dublin 463
Chandler 457
Jacksonville 337
San Jose 327
Singapore 285
Nanjing 272
Ashburn 223
Beijing 217
Hong Kong 191
Dallas 167
Boardman 125
Ann Arbor 116
Nanchang 104
Helsinki 97
Los Angeles 93
Munich 80
Princeton 80
Lawrence 73
Hebei 70
Shenyang 69
Medford 67
Changsha 66
New York 64
Lauterbourg 58
Hanoi 54
Ho Chi Minh City 54
Jiaxing 54
Johannesburg 52
Wilmington 50
Moscow 45
Tianjin 44
Hangzhou 42
Shanghai 37
Buffalo 34
Turku 29
Woodbridge 29
Orem 28
São Paulo 27
Brussels 26
Milan 25
Tokyo 24
Seattle 22
Verona 22
Norwalk 18
Warsaw 17
Chennai 16
Brooklyn 15
London 13
Piscataway 13
Redondo Beach 13
Des Moines 12
Manchester 12
Pavia 12
Denver 11
Montreal 11
Rio de Janeiro 11
Toronto 11
Auburn Hills 10
Fairfield 10
Frankfurt am Main 10
Poplar 10
Santa Clara 10
Da Nang 9
Haiphong 9
Houston 9
Mumbai 8
Tashkent 8
Amsterdam 7
Jinan 7
Washington 7
Zhengzhou 7
Atlanta 6
Baghdad 6
Istanbul 6
Jeddah 6
Ningbo 6
Stockholm 6
Taizhou 6
Berlin 5
Biên Hòa 5
Bắc Ninh 5
Campinas 5
Curitiba 5
Kunming 5
Mexico City 5
Naples 5
Amman 4
Cape Town 4
Changchun 4
Chicago 4
Council Bluffs 4
Falkenstein 4
Hanover 4
Kuala Lumpur 4
Lanzhou 4
Medellín 4
Nairobi 4
Paris 4
Phoenix 4
Pune 4
Totale 5.243
Salva come PNG Salva come JPEG
Nome #
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 162
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 155
Significato prognostico dei livelli plasmatici di osteopontina in pazienti con angina pectoris stabile 148
Approccio genetico-clinico alla cardiopatia ischemica: analisi di 14 casi familiari. 145
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 143
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 140
Diabetes mellitus and silent myocardial ischemia in patients with coronary artery disease: comparison between patients with and without simptoms during provocative test. 139
374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis 137
RAGE : a central player in nondiabetic vascular disease 136
La chemochina regolatoria eotaxina-3 quale nuovo fattore predittivo di outcome cardiovascolare in pazienti con angina pectoris stabile 136
Decreased NT-3 plasma levels and platelet serotonin content in patients with hypochondriasis 136
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 135
A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction 132
Apo(a) isoforms: a genetic marker for progression of coronary atherosclerosis. 132
Analisi mutazionale di Kir6.1/KCNJ8 in pazienti con angina vasospastica 131
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 129
Circulating levels of osteopontin predicts future cardiac events in patients with chronic stable angina 129
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 129
QT interval duration in apparently healthy men is associated with depression-related personality trait neuroticism 129
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 128
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 128
Forma solubile del recettore dei prodotti finali di glicazione avanzata (sRAGE) ed aterosclerosi coronarica 128
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects 128
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 127
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension 125
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 124
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 123
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 120
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 120
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 119
Raised plasma nerve growth factor levels associated with early-stage romantic love 117
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 117
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 116
Cerebral ischemia and peripheral energy dysfunction in lymphocytes 115
Action of piracetam and clonidine on different mitochondrial populations from hippocampus 115
Disfunzione erettile come predittore di eventi cardiovascolari maggiori in diabetici con coronaropatia silente angiograficamente documentata 111
Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. 110
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. 108
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 106
ATPases enzyme activities during ageing in different types of somatic and synaptic plasma membranes from rat frontal cerebral cortex 106
Enzyme activities in perikaryal and synaptic mitochondrial fractions from rat hippocampus during development 105
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 103
High Lp(a) levels and atherogenic isoforms in patients with acute coronary sindrome 102
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 101
Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients 99
Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism. 98
Functional proteomics of energy-linked enzymes in lymphocytes after stroke. 97
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. 97
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 95
Prognostic significance of plasma osteopontin levels in patients with chronic stable angina 95
The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. 92
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus 89
Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target 88
Increased Plasma Aldosterone Concentrations in Patients with Clinical Depression 88
Matrix metalloproteinase 2 and 9 evaluation in patients with or without diabetes during acute coronary syndrome and after the acute event 87
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: a 5-year follow-up study 87
Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role? 87
Genetic loading on human loving styles 86
Fenotipi di apolipoproteina(a) come indicatori di suscettibilità genetica per rischio cardiovascolare in medicina del lavoro 83
Factors involved in drug interference on enzyme activities of three mitochondrial populations from rat hippocampus 82
The apolipoprotein(a) size polymorphism is assocated with Alzheimer's disease and vascular dementia 81
Peripheral energy dysfunction in cerebral ischemia: focus on lymphocytes. 75
Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients 75
Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes 74
Relationship between platelet serotonin content and rejections of unfair offers in the ultimatum game. 73
Energy metabolism of mitochondria after ischemia and recovery times during aging and peripheral energy dysfunction in stroke patients: focus on lymphocytes 73
Valutazione delle metalloproteasi 2 e 9 in pazienti con o senza diabete durante sindrome coronarica acuta e dopo evento acuto 73
Energy metabolism of lymphocytes from acute stroke patients 72
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 72
Prevalenza di elevati livelli di Lp(a) e di isoforme aterogene in un gruppo di pazienti del Nord Italia con sindrome coronarica acuta 71
Lymphocytes bioenergetics after stroke: a functional proteomic study 71
Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects 66
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 64
Totale 7.915
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.237
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021155 0 0 0 0 0 0 0 0 0 74 66 15
2021/2022326 7 3 9 8 2 5 8 20 16 19 49 180
2022/20231.338 139 107 17 98 149 124 0 78 556 17 34 19
2023/2024424 77 85 11 26 34 95 4 37 3 13 19 20
2024/20251.128 18 82 50 32 34 38 44 80 290 33 149 278
2025/20262.476 219 140 258 304 325 143 635 111 199 142 0 0
Totale 7.915